Loading clinical trials...

COMPLETEDPhase 3NCT02506868

Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

The purpose of the study is to prove equivalence of efficacy and safety of BCD-066 and Aranesp® in treatment of anemia in end-stage chronic kidney disease patients on dialysis.

Lead sponsor: Biocad•30 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

NCT06474169 · Chronic Kidney Diseases

RECRUITING

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

NCT07649031 · Fanconi Anemia

RECRUITINGPhase 2

Equol and Vascular Function in Women With Chronic Kidney Disease

NCT07194590 · Chronic Kidney Disease (Stage 3-4), Vascular Function, and more

RECRUITING

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)

NCT07593352 · IBD and Renal Involement, Chronic Kidney Disease, and more

RECRUITINGPhase 2

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 7, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment196

Start dateAug 2015

Last updatedMay 7, 2020

Condition

Chronic Kidney Disease End Stage Renal Failure on Dialysis Anemia

Locations shown

St. Josaphat Belgorod Regional Clinical Hospital

Belgorod

Alyans Biomedical - Ural'skaya gruppa

Izhevsk

Kaluga Region Hospital

Kaluga

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 7, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

Equol and Vascular Function in Women With Chronic Kidney Disease

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Trial snapshot

Condition

Locations shown

For caregivers